Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis
Rihab Bouchareb(Temple University), Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec), Lionel Tastet(Institut universitaire de cardiologie et de pneumologie de Québec), Ghada Mkannez(Université Laval), Fayez Hadji(Valve (United States)), Marie‐Chloé Boulanger(Institut universitaire de cardiologie et de pneumologie de Québec), Mohamed Jalloul Nsaibia(Institut Universitaire de Cardiologie et de Pneumologie de Québec), Benoît J. Arsenault(Emory University), Yohan Bossé(Institut universitaire de cardiologie et de pneumologie de Québec), Younes Messadeq(Université Laval), André Marette(Université Laval), Abdellaziz Dahou(Valve (United States)), Philippe Pîbarot(Emory University)
Cited by 86
Related Papers
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
|The Lancet|2016|1k
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2020|832